Pregenerate Overview
- Year Founded
-
2019
- Status
-
Out of Business
- Employees
-
3
- Latest Deal Type
-
Out of Business
- Investors
-
1
Pregenerate General Information
Description
Developer of a cartilage-on-a-chip technology designed to support arthritis treatment. The company's technology uses scalable organ-on-a-chip models and offers products and services to replace expensive and inefficient animal testing in medical and pharmaceutical research, enabling healthcare providers to understand personalized responses to different treatment options to replace animal testing in research for arthritis treatments.
Contact Information
Website
www.pregenerate.netCorporate Office
- Dr.-Bohr-Gasse 7/3/311
- Vienna, 1030
- Austria
Corporate Office
- Dr.-Bohr-Gasse 7/3/311
- Vienna, 1030
- Austria
Pregenerate Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Out of Business | 26-Nov-2025 | Completed | Out of Business | |||
| 8. Early Stage VC | Cancelled | Generating Revenue | ||||
| 7. Early Stage VC | Cancelled | Generating Revenue | ||||
| 6. Early Stage VC | 07-Jun-2022 | Completed | Generating Revenue | |||
| 5. Seed Round | 06-Oct-2020 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 12-Feb-2019 | Completed | Startup | |||
| 3. Seed Round | 01-Jan-2019 | Completed | Startup | |||
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. University Spin-Out | 01-Jan-2019 | Completed | Startup |
Pregenerate Comparisons
Industry
Financing
Details
Pregenerate Competitors (3)
One of Pregenerate’s 3 competitors is Foundation Medicine, a Formerly VC-backed company based in Boston, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Foundation Medicine | Formerly VC-backed | Boston, MA | ||||
| Emulate | Venture Capital-Backed | Boston, MA | ||||
| ImageBiopsy Lab | Venture Capital-Backed | Vienna, Austria |
Pregenerate Patents
Pregenerate Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202305410-D0 | Analysis of treatment efficacy | Inactive | 13-Apr-2023 | ||
| WO-2024213484-A1 | Analysis of treatment efficacy | Inactive | 13-Apr-2023 | ||
| WO-2024213483-A1 | Evaluation of treatment efficacy | Inactive | 13-Apr-2023 | ||
| GB-202305403-D0 | Evaluationof treatment efficacy | Inactive | 13-Apr-2023 | ||
| GB-202006097-D0 | Method of testing for infectious disease and system for reporting result | Inactive | 25-Apr-2020 |
Pregenerate Signals
Pregenerate Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| TU Wien | University |
Pregenerate FAQs
-
When was Pregenerate founded?
Pregenerate was founded in 2019.
-
Where is Pregenerate headquartered?
Pregenerate is headquartered in Vienna, Austria.
-
What is the size of Pregenerate?
Pregenerate has 3 total employees.
-
What industry is Pregenerate in?
Pregenerate’s primary industry is Monitoring Equipment.
-
Is Pregenerate a private or public company?
Pregenerate is a Private company.
-
What is Pregenerate’s current revenue?
The current revenue for Pregenerate is .
-
How much funding has Pregenerate raised over time?
Pregenerate has raised $897K.
-
Who are Pregenerate’s investors?
TU Wien has invested in Pregenerate.
-
Who are Pregenerate’s competitors?
Foundation Medicine, Emulate, and ImageBiopsy Lab are competitors of Pregenerate.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process